In addition, RMRP was recently demonstrated to be up-regulated in liver of patients affected by non-alcoholic fatty liver disease (NAFLD); its inhibition decreased steatosis and lipid deposition in a NAFLD rat model [54]. Here, RMRP is linked to metabolic dysfunction-associated steatotic liver disease.